The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the world
is still expanding. Thus, there is an urgent need to better understand this novel virus and find …

Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the
effort against the COVID‐19 outbreak starting in late 2019, although the history of mRNA …

Background In recent months numerous health care professional acquired COVID-19 at the
workplace resulting in significant shortages in medical and nursing staff. We investigated …

Background SARS‐CoV‐2 has spread worldwide causing more than 400 million people
with virus infections since early 2020. Currently, the existing vaccines targeting the spike …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
pandemic of the Coronavirus disease in late 2019 (COVID-19). Vaccine development efforts …

Background. In 2020, the pandemic caused by novel coronavirus infection has become one
of the most critical global health challenges during the past century. The lack of a vaccine, as …

New variants in the SARS‐CoV‐2 pandemic are more contagious (Alpha/Delta), evade
neutralizing antibodies (Beta), or both (Omicron). This poses a challenge in vaccine …

The COVID-19 pandemic caused by SARS-CoV-2 infection poses a serious threat to public
health. An explicit investigation of COVID-19 immune responses, particularly the host …

SARS-CoV-2 is a highly contagious coronavirus causing the ongoing pandemic. Very
recently its genomic RNA of∼ 30 kb was decoded to be packaged with nucleocapsid (N) …

SARS-CoV-2 has caused a global pandemic, infecting millions of people. An effective
preventive vaccine against this virus is urgently needed. Here, we designed and developed …